Skip to content

A comparative study between a modified traditional transscleral cyclophotocoagulation technique and the current standard technique in eyes with refractory glaucoma

A prospective, randomized, comparative, examiner-masked study comparing a modification of the traditional transscleral cyclophotocoagulation technique with slow coagulation in eyes with refractory glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-29x7rhy
Enrollment
Unknown
Registered
2025-12-24
Start date
2023-02-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmic surgical procedures

Interventions

A prospective, randomized, comparative, and single-masked study was conducted, comparing a modification of the traditional transscleral cyclophotocoagulation technique with slow coagulation in eyes wi
clock positions) per eye. A total of 21 applications were delivered, with 3 applications

Sponsors

Universidade Federal de Goiás
Lead Sponsor
Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 18 years or older; patients of any gender; patients who have undergone previous surgical interventions for glaucoma or not (excluding cyclodestructive procedures); patients previously operated on for glaucoma who experienced failure of such procedure(s) and did not achieve target intraocular pressure under maximally tolerated medication at medical discretion; patients with other subtypes of glaucoma classified as refractory glaucoma, such as neovascular glaucoma, glaucoma in aphakic eyes, inflammatory glaucoma, glaucoma associated with corneal transplant, post-vitreoretinal surgery glaucoma (with or without silicone oil implant), post-traumatic glaucoma; patients with glaucoma in eyes with conjunctiva unsuitable for filtering surgeries; patients with absolute glaucoma and a history of pain associated with marked ocular hypertension

Exclusion criteria

Exclusion criteria: Pregnant patients; lactating patients; patients with unknown or non-glaucoma related vision loss/deficit in any eye; history of previous cyclodestructive surgery; patients with a history of corneal refractive surgery; glaucoma with active uveitis; patient's inability to return on scheduled dates; patient's refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
After 12 months of follow-up, a significant reduction in intraocular pressure, of approximately one-third of the preoperative value, is expected in both the experimental group and the control group

Secondary

MeasureTime frame
A significant reduction in the number of hypotensive eye drops required for intraocular pressure control is also expected, with the reduction being on the order of two eye drops in both groups;It is presumed that certain preoperative factors may be considered significant for surgical success or failure: the number of hypotensive eye drops, oral acetazolamide use, race, age, and sex

Countries

Brazil

Contacts

Public ContactEduardo Pereira I

Universidade Federal de Goiás

eduardo.akio@discente.ufg.br+55(62)32096770

Outcome results

None listed

Source: REBEC (via WHO ICTRP)